BioSpace News Archive

Business

Return to play for soccer athletes and risk for future injury

A new study looked at soccer athletes who sustained an anterior cruciate ligament (ACL) reconstruction to better understand the average return to play time and their risk of injury following a revision ACL reconstruction.

March 6, 2018
·
2 min read
Business

Stem cell centers on the rise, claim high efficacy for treatment of knee osteoarthritis despite lack of evidence

High treatment price may be greater than cost for total knee arthroplasty

March 6, 2018
·
4 min read
Business

Vitamin D deficiency and insufficiency impacts children’s risk for severe forearm fractures

Children who are vitamin D deficient have a greater risk of having more severe forearm fractures requiring surgical treatment, according to a new study presented at the 2018 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).

March 6, 2018
·
2 min read
Drug Development

Biohaven Enrolls First Patient In Phase 3 Clinical Trial To Evaluate Rimegepant Zydis® ODT In The Acute Treatment Of Migraine

Biohaven Pharmaceutical Holding Company Ltd. announced that it has enrolled the first patient in a Phase 3 clinical trial of the Zydis® orally dissolving tablet (“ODT”) formulation of rimegepant for the acute treatment of migraine.

March 6, 2018
·
2 min read
BioForest

Achieve Life Sciences Announces Cytisine Symposium at the 17th World Conference on Tobacco or Health

Achieve Life Sciences, Inc. (NASDAQ: ACHV), today announced that the World Conference on Tobacco or Health (WCTOH) will be holding a symposium on cytisine research at this year’s annual conference, March 7-9th in Cape Town, South Africa.

March 6, 2018
·
4 min read
Business

Adicet Bio Announces the Transition of Founder, President and Chief Executive Officer Dr. Aya Jakobovits

Adicet Bio, Inc. (“Adicet”), a biopharmaceutical company focused on the development of next-generation cell immunotherapies, announced today that Aya Jakobovits, Ph.D., Founder of Adicet Bio, has retired from her position as President and Chief Executive Officer.

March 6, 2018
·
2 min read
Business

TissueTech, Inc. Names Adrian Roji Chief Commercial Officer

New Chief Commercial Officer brings broad experience in regenerative medicine

March 6, 2018
·
2 min read
Drug Development

Apexigen and the Pediatric Brain Tumor Consortium Announce a Clinical Collaboration to Evaluate APX005M in Children with Brain Tumors

Study to evaluate the safety and tolerability of APX005M, a CD40 agonistic antibody, in pediatric patients with recurrent or refractory brain tumors

March 6, 2018
·
4 min read
Business

Ora, Inc. Unifies its Clinical Environment with Veeva to Accelerate Trial Execution

Fast-growing CRO adopts Veeva Vault Clinical Suite to drive greater efficiency and visibility across global studies

March 6, 2018
·
4 min read
Biotech Beach

Imprimis Pharmaceuticals Announces Program for Custom Compounded Ophthalmic Formulations

Company dedicated to meeting the need for critical, hard-to-find medications with ease of access

March 6, 2018
·
4 min read